Tolaasin I and the White Line Inducing Principle (WLIP) are lipodepsipeptides (LDPs) produced by virulent strains of Pseudomonas tolaasii and P. reactans which are the causal agents of “brown blotch” disease of Agaricus bisporus and of the “yellowing” of Pleurotus ostreatus. Both tolaasin I and WLIP have haemolytic activity, permeabilize lipid vesicles and appear to be involved in mushroom tissue alterations by forming transmembrane pores. Herein, we describe the activity of tolaasin II and five natural tolaasin analogues on natural and model membranes. Tolaasin I and tolaasin II shared similar activity; the other tolaasin analogues were instead remarkably less active (up to 15 times when compared to tolaasin I) both on natural and model membranes. Additionally, the activity of mixtures formed by tolaasin I and WLIP on vesicles is reported. Preliminary evidences of an interaction of the two LDPs leading to an antagonistic action became apparent.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Bassarello, C., Lazzaroni, S., Bifulco, G., Lo Cantore, P., Iacobellis, N. S., Riccio, R., Gomez-Paloma, L., and Evidente, A., 2004, Tolaasins A-E, five new lipodepsipeptides produced by Pseudomonas tolaasii. J. Nat. Prod., 67, 811–816.
Brodey, C. L., Rainey, P. B., Tester, M., and Johnstone, K., 1991, Bacterial blotch disease of the cultivated mushroom is caused by an ion channel forming lipodepsipeptide toxin. Mol. Plant Microbe Interact., 4, 407–411.
Cho, K. H. and Kim, Y. K., 2003, Two types of ion channel formation of tolaasin, a Pseudomonas peptide toxin. FEMS Microbiol. Lett., 221, 221–226.
Coraiola, M., Lo Cantore, P., Lazzaroni, S., Evidente, A., Iacobellis, N.S., and Dalla Serra, M., 2006, Tolaasin I and WLIP, Lipodepsipeptides from Pseudomonas tolaasii and P. reactans, permeabilize model membranes. Biochim. Biophys. Acta, 1758, 1713–1722.
Dalla Serra, M., Fagiuoli, G., Nordera, P., Bernhart, I., Della Volpe, C., Di Giorgio, D., Ballio, A., and Menestrina, G., 1999, The interaction of lipodepsipeptide toxins from Pseudomonas syringae pv. syringae with biological and model membranes: a comparison of syringotoxin, syringomycin and syringopeptins. Mol. Plant Microbe Interact., 12, 391–400.
Dalla Serra, M., Menestrina, G., Coraiola, M., and Grgurina, I., 2003, Interaction of syringomycin E structural analogues with biological and model membranes. In Iacobellis, S. N. (Ed.), Pseudomonas syringae and related pathogens. Biology and Genetic, Kluwer, Dordrecht (NL), pp. 207–215.
Godfrey, S. A., Marshall, J. W., and Klena, J. D., 2001, Genetic characterization of Pseudomonas ‘NZI7’–a novel pathogen that results in a brown blotch disease of Agaricus bisporus. J. Appl. Microbiol., 91, 412–420.
Hutchison, M. L. and Johnstone, K., 1993, Evidence for the involvement of the surface active properties of the extracellular toxin tolaasin in the manifestation of the brown blotch disease symptoms by Pseudomonas tolaasii on Agaricus bisporus. Physiol. Mol. Plant Pathol., 42, 373–384.
Iacobellis, N. S. and Lo Cantore, P., 2003, Pseudomonas reactans a new pathogen of cultivated mushrooms. In Iacobellis, N. S. (Ed.), Pseudomonas syringae and Related Pathogens. Biology and Genetic, Kluwer, Dordrecht (NL), pp. 595–605.
Limpel, L. E., Schuldt, P. H., and Lamont, D., 1962, Weed control by dimethyl tetrachloroterephthalate alone and in certain combinations. Proc. North. Weed Control Conf., 16, 48–53.
Lo Cantore, P., Lazzaroni, S., Coraiola, M., Dalla Serra, M., Cafarchia, C., Evidente, A., and Iacobellis, N. S., 2006, Biological Characterisation of WLIP produced by Pseudomonas reactans strain NCPPB1311. Mol. Plant Microbe Interact., 19, 1113–1120.
Mortishire-Smith, R. J., Drake, A. F., Nutkins, J. C., and Williams, D. H., 1991a, Left handed alpha-helix formation by a bacterial peptide. FEBS Lett., 278, 244–246.
Mortishire-Smith, R. J., Nutkins, J. C., Packman, L. C., Brodey, C. L., Rainey, P. B., Johnstone, K., and Williams, D. H., 1991b, Determination of the structure of an extracellular peptide produced by the mushroom saprophytic Pseudomonas reactans. Tetrahedron, 47, 3645–3654.
Munsch, P., Alatossava, T., Marttinen, N., Meyer, J. M., Christen, R., and Gardan, L., 2002, Pseudomonas costantinii sp. nov., another causal agent of brown blotch disease, isolated from cultivated mushroom sporophores in Finland. Int. J. Syst. Evol. Microbiol., 52, 1973–1983.
Nutkins, J. C., Mortishire-Smith, R. J., Packman, L. C., Brodey, C. L., Rainey, P. B., Johnstone, K., and Williams, D. H., 1991, Structure determination of tolaasin, an extracellular lipodepsipeptide produced by the mushroom pathogen Pseudomonas tolaasii Paine. J. Am. Chem. Soc., 113, 2621–2627.
Rainey, P. B., Brodey, C. L., and Johnstone, K., 1992, Biology of Pseudomonas tolaasii, cause of brown blotch disease of the cultivated mushroom. Adv. Plant Pathol., 8, 95–117.
Tolaas, A. G., 1915, A bacterial disease of cultivated mushrooms. Phytopathology, 5, 51–53.
Wong, W. C. and Preece, T. F., 1979, Identification of Pseudomonas tolaasii: the white line in agar and mushroom tissue block rapid pitting tests. J. Appl. Bacteriol., 47, 401–407.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science + Business Media, B.V
About this chapter
Cite this chapter
Paletti, R. et al. (2008). WLIP and Analogues of Tolaasin I, Lipodepsipeptides from Pseudomonas reactans and Pseudomonas tolaasii: A Comparison of Their Activity on Natural and Model Membranes. In: Fatmi, M., et al. Pseudomonas syringae Pathovars and Related Pathogens – Identification, Epidemiology and Genomics. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-6901-7_20
Download citation
DOI: https://doi.org/10.1007/978-1-4020-6901-7_20
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-6900-0
Online ISBN: 978-1-4020-6901-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)